Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-24

Clinical Trial Update: A Study to Assess the Bioequivalence of Famotidine/Antacid Combination Tablets Compared to Famotidine/Antacid EZ Chew Tablets (0208C-145)(COMPLETED) [Phase 1]

View source ↗

Summary

A Phase 1 study completed to compare the bioequivalence of a famotidine/antacid combination tablet with the famotidine/antacid EZ Chew tablet in individuals wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famotidine/antacid EZ Chew tablets (famotidine/antacid)
  • Famotidine/antacid combination tablets (famotidine/antacid)

Snippet

Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide | Conditions: Heartburn | Phase 1 | Status: COMPLETED | Results posted: 2015-06-24